Charles Schwab Investment Management Inc. Buys 18,555 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Charles Schwab Investment Management Inc. grew its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 8.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 227,209 shares of the company’s stock after buying an additional 18,555 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.25% of Addus HomeCare worth $30,226,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its position in shares of Addus HomeCare by 33.8% during the second quarter. GAMMA Investing LLC now owns 744 shares of the company’s stock worth $86,000 after purchasing an additional 188 shares during the period. SG Americas Securities LLC acquired a new stake in shares of Addus HomeCare during the second quarter worth about $842,000. Chatham Capital Group Inc. raised its position in shares of Addus HomeCare by 1.2% during the second quarter. Chatham Capital Group Inc. now owns 21,609 shares of the company’s stock worth $2,509,000 after purchasing an additional 265 shares during the period. Diversified Trust Co raised its position in shares of Addus HomeCare by 9.4% during the second quarter. Diversified Trust Co now owns 2,673 shares of the company’s stock worth $310,000 after purchasing an additional 230 shares during the period. Finally, Ellsworth Advisors LLC acquired a new stake in shares of Addus HomeCare during the second quarter worth about $598,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Up 1.1 %

NASDAQ:ADUS opened at $123.60 on Thursday. The firm has a market capitalization of $2.24 billion, a price-to-earnings ratio of 28.28, a price-to-earnings-growth ratio of 2.15 and a beta of 1.01. Addus HomeCare Co. has a twelve month low of $85.94 and a twelve month high of $136.12. The stock’s 50 day moving average price is $126.69 and its two-hundred day moving average price is $123.92.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.03 EPS. As a group, analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 12.93 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. TD Cowen raised their price target on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Oppenheimer raised their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. Finally, KeyCorp assumed coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.